Lora Baker, DPM
Foot Surgery · Allentown, PANPI 1235114331
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 50 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Smith+Nephew at 33.1% of the total. 2025 is the largest year on record at $679, 9.8 times the $69 reported in 2019.
Across 50 payments — averaging $37.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$627
- Stryker$585
- Organogenesis Inc.$244
- Averitas Pharma Inc.$84
- Nevro Corp.$70
- Convatec Inc.$57
- plus $228 from 9 others
What the payments were for
- Food & beverage$1,895100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 20 | $627 |
| Stryker | 5 | $585 |
| Organogenesis Inc. | 5 | $244 |
| Averitas Pharma Inc. | 4 | $84 |
| Nevro Corp. | 4 | $70 |
| Convatec Inc. | 2 | $57 |
| GRT US Holding, Inc. | 2 | $53 |
| KCI USA, Inc. | 1 | $29 |
| DJO, LLC | 1 | $29 |
| Zyla Life Sciences, Inc. | 1 | $28 |
| Kerecis Limited | 1 | $22 |
| Paratek Pharmaceuticals, Inc. | 1 | $20 |
| Novus Surgical Consultants | 1 | $18 |
| Globus Medical | 1 | $17 |
| Integra Lifesciences Corporation | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- STRAVIX PL$148
- GRAFIX PL$148
- OASIS MICRO$148
- INFINITY$142
- ORTHOLOC 2 LAPIFUSE$140
- PHALINX$140
- AUGMENT INJECTABLE$140
- ALLOWRAP$139
- SONICPIN$105
How this compares
$1,895 in reported general payments places this provider in the 80th percentile of 67 foot surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 31 | $867 |
| Doxycycline Hyclate | 28 | $223 |
| Cephalexin | 39 | $209 |
| Terbinafine Hcl | 20 | $196 |
| Mupirocin | 19 | $189 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Allentown
- Raymond FritzAllentown$2K
- Mark MaehrerAllentown$1K
- Neal KramerAllentown$740
- Joshua ScollBensalem$18K
- Derrico QuattroneJefferson Hills$6K
- Dawn SteinGrove City$5K
- Robert NortonPhiladelphia$4K
- Alyssa FitchLancaster$4K
- Peter LarnedKing Of Prussia$3K
- Nikki MiracleBeaver Falls$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.